Skip to content

ADC Therapeutics SA

ADCT· NYSECore metricsCIK 1771910

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -12.23%
Market cap
$178.83M
127.74M shares
Filings
442
$21.01M
Q3 2026+14.9% FY25 yoy
-$25.30M
Q3 2026N/M FY25 yoy
-$14.35M
Q3 2026N/M FY25 yoy
-$69.43M
Q3 2026derivedN/M FY25 yoy
-$0.16
Q3 2026N/M FY25 yoy
$189.20M
Q3 2026+4.2% FY25 yoy
$178.83M
—
2.0×
—
-56.23%
—

Twelve months to Sep 30, 2026 · derived

Price

$1.4064.78%$2.58past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$81.36MFY 2025
$81.36M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$81,357,000reported
FY 20242024-12-31$70,837,000reported
FY 20232023-12-31$69,060,000 revisedreported
FY 20222022-12-31$74,908,000 revisedreported
FY 20212021-12-31$33,917,000reported
FY 20202020-12-31$0reported
FY 20192019-12-31$2,340,000reported
FY 20182018-12-31$1,140,000reported

Capital returns

Dividends and buybacks · FY2018 to FY2021
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2021—$0.00$0.00—76.81M sh+0.1%—
FY2020—$0.00$0.00—76.72M sh——
FY2019—$141.00K$141.00K————
FY2018—$0.00$0.00————

Segments

Revenue by Geography, FY2022 to FY2025FY2022U.S. · FY2022 · $74.91MEMEA · FY2022 · $105.00MJapan · FY2022 · $30.00MFY2023U.S. · FY2023 · $69.06MEMEA · FY2023 · $498.00KFY2024U.S. · FY2024 · $69.28MEMEA · FY2024 · $1.56MFY2025U.S. · FY2025 · $73.55MEMEA · FY2025 · $7.81M
LineFY2025ShareChange
U.S.$73.55M90%+6.2%
EMEA$7.81M9.6%+401.3%
Japan———
Total$81.36M

From the 10-K filed Mar 10, 2026ADCT

Pharmaceutical preparations

ADC Therapeutics SA is the 109th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

ADC Therapeutics SA · CIK 1771910 · Engraved from SEC EDGAR